5U6V
X-ray crystal structure of 1,2,3-triazolobenzodiazepine in complex with BRD2(D2)
Summary for 5U6V
Entry DOI | 10.2210/pdb5u6v/pdb |
Descriptor | Bromodomain-containing protein 2, 5-[7-(4-chlorophenyl)-1-methyl-6,7-dihydro-5H-[1,2,3]triazolo[1,5-d][1,4]benzodiazepin-9-yl]pyridin-2-amine, 1,2-ETHANEDIOL, ... (4 entities in total) |
Functional Keywords | bromodomain, benzodiazepine, epigenetics, transcription-transcription inhibitor complex, transcription/transcription inhibitor |
Biological source | Homo sapiens (Human) |
Cellular location | Nucleus : P25440 |
Total number of polymer chains | 1 |
Total formula weight | 13628.02 |
Authors | Hatfaludi, T.,Sharp, P.P.,Garnier, J.-M.,Burns, C.J.,Czabotar, P.E. (deposition date: 2016-12-09, release date: 2017-12-13, Last modification date: 2024-03-06) |
Primary citation | Sharp, P.P.,Garnier, J.M.,Hatfaludi, T.,Xu, Z.,Segal, D.,Jarman, K.E.,Jousset, H.,Garnham, A.,Feutrill, J.T.,Cuzzupe, A.,Hall, P.,Taylor, S.,Walkley, C.R.,Tyler, D.,Dawson, M.A.,Czabotar, P.,Wilks, A.F.,Glaser, S.,Huang, D.C.S.,Burns, C.J. Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors. ACS Med Chem Lett, 8:1298-1303, 2017 Cited by PubMed: 29259751DOI: 10.1021/acsmedchemlett.7b00389 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.775 Å) |
Structure validation
Download full validation report